Elimination disorders are among the most common reasons children are referred to behavioral health, yet they are frequently mismanaged as either purely medical or purely psychological problems when they are almost always both. DSM-5-TR groups Enuresis and Encopresis as distinct diagnoses requiring a developmental age threshold, a minimum symptom frequency and duration, and exclusion of substances and general medical conditions that fully account for the symptoms. Both conditions carry meaningful psychosocial morbidity — shame, social withdrawal, parent–child conflict, and increased risk of maltreatment — but most cases resolve with structured behavioral treatment, with pharmacotherapy reserved for specific scenarios. Encopresis is dominated by functional constipation with retentive overflow, so disimpaction and maintenance laxatives are the foundation rather than psychiatric medication. The bottom line: treat the bowel and bladder first, treat the family system in parallel, and reserve psychotropics for comorbid conditions.

Enuresis and encopresis are common pediatric conditions whose prevalence falls steeply with age. Both show a male predominance and substantial overlap with neurodevelopmental and disruptive behavior disorders.

Enuresis prevalence

• Nocturnal enuresis affects approximately 5–10% of 7-year-olds and 1–2% of adolescents, with spontaneous annual remission of roughly 15% in untreated children.^1-2
• Daytime (diurnal) urinary incontinence is less common, affecting roughly 2–4% of school-aged children, and more often signals an underlying functional bladder disorder.^1,3
• Male-to-female ratio is approximately 2:1 for nocturnal enuresis; daytime wetting is more common in girls.^1-2

Encopresis prevalence

• Encopresis affects roughly 1–4% of school-aged children, with a male predominance of about 3–6:1.^4-5
• Functional constipation underlies an estimated 80–95% of encopresis cases (retentive subtype).^4,6

Comorbidity and risk factors

• Comorbid ADHD, anxiety disorders, oppositional defiant disorder, and developmental delay are overrepresented in both conditions.^2,7
• Family history is strong for nocturnal enuresis: a child with two affected parents has roughly a 70–75% risk; with one affected parent, roughly 40–45%.^2,8
• Psychosocial stressors (birth of a sibling, parental separation, school transition, sexual abuse) can precipitate secondary cases.^5,7
• Encopresis in a previously continent child raises concern for psychosocial trauma, including sexual abuse, though the majority of cases remain functional.^5,7

Both disorders reflect a developmental mismatch between physiologic readiness and the demands of continence, layered on heritable predisposition and modifiable environmental factors. Mechanisms differ meaningfully between enuresis subtypes and between retentive and non-retentive encopresis.

Nocturnal enuresis

• Three-system model: nocturnal polyuria (often from reduced overnight Vasopressin secretion), reduced functional bladder capacity or detrusor overactivity, and high arousal threshold from sleep.^2,8
• Genetic linkage studies have identified loci on chromosomes 12q, 13q, and 22q, consistent with high heritability and an autosomal dominant pattern with incomplete penetrance in many families.^2,8
• Constipation independently impairs bladder function by mechanical compression and shared neural reflexes; treating constipation often improves enuresis even without bladder-specific therapy.^3,6

Daytime urinary incontinence

• Most cases reflect functional bladder disorders — overactive bladder, dysfunctional voiding, or voiding postponement — rather than structural disease.³
• A minority are explained by urinary tract infection, ectopic ureter, neurogenic bladder, or posterior urethral valves; these are exclusions, not differentials.³

Encopresis pathophysiology

• Retentive (functional) encopresis: chronic stool withholding leads to rectal distension, decreased rectal sensation, megarectum, and overflow incontinence of liquid stool around an impaction.^4,6
• Common triggers for withholding include painful defecation from a hard stool, coercive toilet training, and avoidance of school bathrooms.^4-5
• Non-retentive encopresis is less common and more strongly associated with oppositional behavior, developmental delay, and psychosocial stressors.^5,7

DSM-5-TR codes enuresis and encopresis under elimination disorders, requiring a developmental-age threshold, a minimum frequency and duration, and exclusion of fully explanatory medical or substance-related causes.⁹ Subtypes turn on timing (enuresis) or presence of overflow incontinence (encopresis).

Enuresis criteria

• Repeated voiding of urine into bed or clothes, whether involuntary or intentional.⁹
• At least twice weekly for three consecutive months, or clinically significant distress or functional impairment.⁹
• Chronologic age at least 5 years, or equivalent developmental level.⁹
• Not attributable to a substance (e.g., diuretic, antipsychotic) or another medical condition (e.g., diabetes, spina bifida, seizure disorder).⁹

Enuresis subtypes

• Nocturnal only: most common; further classified as primary (never achieved continence for ≥6 months) or secondary (relapse after ≥6 months dry).⁹
• Diurnal only: wetting during waking hours.⁹
• Nocturnal and diurnal: both patterns present.⁹

Encopresis criteria

• Repeated passage of feces into inappropriate places (clothing, floor), whether involuntary or intentional.⁹
• At least one event per month for three consecutive months.⁹
• Chronologic age at least 4 years, or equivalent developmental level.⁹
• Not attributable solely to a substance or to a general medical condition except through a mechanism involving constipation.⁹

Encopresis subtypes

• With constipation and overflow incontinence (retentive): the dominant subtype; stools are typically poorly formed and leak continuously or near-continuously.⁹
• Without constipation and overflow incontinence (non-retentive): stools are normally formed and deposited in inappropriate locations, often in a patterned way.⁹

Presentations cluster into recognizable patterns once subtype is established, and the family's framing of the symptom often matters as much as the symptom itself. Children rarely present spontaneously; they arrive because a parent, teacher, or sibling has noticed.

Primary nocturnal enuresis pattern

• Child has never achieved a sustained dry-night interval of six months.^2,9
• Wetting typically occurs in the first third of the night, often soon after sleep onset.²
• The child is usually difficult to rouse and has no recollection of the event in the morning.²
• Family history is frequently positive in first-degree relatives.^2,8

Secondary nocturnal enuresis pattern

• Onset follows a sustained dry interval and often coincides with a psychosocial stressor or new medical issue.^5,7
• Warrants more thorough medical evaluation than primary enuresis, particularly for diabetes, urinary tract infection, and obstructive sleep apnea.^1,3

Daytime urinary incontinence pattern

• Urgency, frequency, holding maneuvers (Vincent's curtsy, leg crossing, squatting on a heel), and small-volume voids point to detrusor overactivity.³
• Infrequent voiding (≤3 times per day), large-volume voids, and constipation point to voiding postponement.³
• Staccato or interrupted urinary stream and incomplete emptying suggest dysfunctional voiding.³

Retentive encopresis pattern

• A history of painful or large-caliber stools, prolonged intervals between bowel movements, and frequent small-volume soiling of liquid or pasty stool.^4,6
• Parents often describe the child as having "diarrhea" — soiling between hard infrequent stools is the classic overflow pattern.^4,6
• Abdominal exam may reveal palpable stool in the left lower quadrant; rectal exam, when indicated, demonstrates a dilated rectum loaded with stool.^4,6

Non-retentive encopresis pattern

• Normally formed stools deposited in inappropriate locations, often patterned (same time of day, same place).^5,9
• Frequently accompanied by oppositional behaviors, developmental delay, or a clear psychosocial stressor.^5,7

The first job is to exclude medical mimics that change management entirely. The second is to recognize coexisting conditions that influence prognosis and treatment.

Medical mimics — enuresis

• Type 1 or type 2 diabetes mellitus: polyuria, polydipsia, weight loss; check fasting glucose and urinalysis.^1,3
• Diabetes insipidus: dilute polyuria; check serum sodium and urine osmolality if clinically suspected.¹
• Urinary tract infection: dysuria, urgency, fever; urinalysis and culture.³
• Posterior urethral valves, ectopic ureter, neurogenic bladder: abnormal stream, continuous dribbling, abnormal neurologic exam; renal-bladder ultrasound and urology referral.³
• Obstructive sleep apnea: snoring, witnessed apneas, daytime fatigue; treating OSA can resolve enuresis in some children.²
• Seizure disorder (especially nocturnal): nocturnal tongue biting, post-ictal confusion, witnessed events.¹

Medical mimics — encopresis

• Hirschsprung disease: history of delayed meconium passage (>48 hours), failure to thrive, empty rectum on exam; suggests aganglionic segment.^4,6
• Hypothyroidism, hypercalcemia: metabolic causes of constipation.⁴
• Spinal dysraphism (tethered cord, sacral agenesis): lower-extremity weakness, sacral dimple, abnormal anal tone.⁴
• Celiac disease, cow's milk protein intolerance: constipation with other GI features.⁶
• Anorectal malformations: structural abnormality usually identified in infancy.⁴

Substance and iatrogenic causes

• Diuretics, lithium, antipsychotics (anticholinergic effects), opioids (constipation), SSRIs (occasional urinary symptoms) can produce symptoms that meet criteria except for the medical-exclusion clause.^9,11

Coexisting psychiatric conditions

• ADHD: strong association with both enuresis and encopresis; treat in parallel rather than sequentially.⁷
• Anxiety disorders, oppositional defiant disorder, autism spectrum disorder: each elevates risk and complicates behavioral treatment adherence.^5,7
• Reactive responses to trauma or abuse: especially in secondary cases or non-retentive encopresis; screen thoughtfully without leading the child.^5,7

Evaluation is primarily clinical, with a focused workup driven by history and exam rather than reflex panels of labs and imaging. The single most useful tool is a structured voiding and stooling diary kept over one to two weeks before the visit.^3-4

History essentials

• Pattern of wetting or soiling: timing (nocturnal vs. diurnal), frequency, volume, duration, and whether primary or secondary.^2-3
• Fluid and caffeine intake, particularly evening consumption.²
• Stooling pattern: frequency, caliber, pain on defecation, blood, withholding posturing.^4,6
• Toilet training history: age started, approach used, regressions.^5,7
• Psychosocial review: school, family changes, abuse screening, bullying.^5,7
• Developmental history and screen for ADHD, autism, anxiety.⁷
• Family history of enuresis and constipation.^2,8
• Medication review including over-the-counter and herbal products.¹¹

Physical exam

• Abdominal exam for palpable stool, distension, masses.^4,6
• External genitourinary exam for structural anomalies, signs of irritation, or evidence of trauma.^3,5
• Lumbosacral spine inspection for dimples, tufts, deviation suggesting spinal dysraphism.⁴
• Focused neurologic exam: lower-extremity strength, deep tendon reflexes, perianal sensation, anal tone if indicated.^3-4
• Growth parameters: failure to thrive shifts the differential.⁴

Validated instruments

• Vancouver Symptom Score for Dysfunctional Elimination Syndrome and the Dysfunctional Voiding Symptom Score quantify daytime urinary symptoms.³
• The Bristol Stool Form Scale standardizes stool consistency reporting.⁶
• A 48-hour voiding diary (times and volumes) and a two-week stool diary inform treatment decisions more than any single-visit assessment.^3-4

Labs and imaging

• Urinalysis for every child with new or daytime symptoms (glucose, specific gravity, leukocytes, nitrites); urine culture if indicated.^1,3
• Targeted bloodwork (glucose, electrolytes, thyroid function, celiac screen) only when clinical features suggest a systemic cause.^1,4
• Renal-bladder ultrasound for refractory daytime symptoms, suspicion of structural anomaly, or recurrent UTI.³
• Plain abdominal radiograph is not routinely required to diagnose functional constipation but can clarify ambiguous cases.⁶
• MRI of the spine only when neurologic findings or cutaneous spinal markers raise concern for occult dysraphism.⁴

Treatment is staged and condition-specific. The unifying principle: address constipation and behavioral foundations first; layer in pharmacotherapy only when behavioral measures fail or specific scenarios demand a faster response.

Pharmacotherapy

• Desmopressin (oral or sublingual) for nocturnal enuresis: evidence suggests effectiveness for short-term dryness, particularly for sleepovers and camps, with high relapse on discontinuation; intranasal formulation is no longer recommended for enuresis in children due to hyponatremia risk.^2,11-12
• Anticholinergics (oxybutynin, tolterodine) for daytime overactive bladder or refractory enuresis with detrusor overactivity; common adverse effects include dry mouth, constipation, and behavioral changes.^3,11
• Imipramine has historical evidence for nocturnal enuresis but is rarely used now given cardiotoxicity in overdose and the availability of safer agents.^2,11
• Polyethylene glycol (PEG 3350) is the first-line maintenance laxative for encopresis with constipation, with stronger evidence than lactulose, mineral oil, or stimulant laxatives in children.^6,13
• Disimpaction precedes maintenance: oral high-dose PEG (1–1.5 g/kg/day for 3–6 days) is generally as effective as enemas and better tolerated.^6,13

Psychotherapy

• Enuresis alarm therapy is first-line behavioral treatment for monosymptomatic nocturnal enuresis: strong evidence supports superior long-term dryness compared with desmopressin, with effectiveness rates of roughly 60–70% and lower relapse, contingent on family adherence over 8–16 weeks.^2,14
• Behavioral interventions for encopresis combine scheduled toileting (sitting on the toilet for 5–10 minutes after meals to use the gastrocolic reflex), positive reinforcement, and demystification.^4-5
• Parent training reduces coercive toileting practices and parent–child conflict, both of which worsen outcomes.^5,7
• Cognitive-behavioral therapy for comorbid anxiety, oppositional behavior, or trauma sequelae improves both psychiatric symptoms and elimination outcomes when comorbidity is present.^5,7

Neuromodulation

• Transcutaneous electrical nerve stimulation (TENS) and parasacral nerve stimulation have limited evidence for refractory overactive bladder in children; not first-line and offered only in specialized pediatric urology settings.³
• Sacral neuromodulation is investigational in pediatric populations and reserved for severe refractory cases.³

Adjunctive

• Fluid management: front-load daytime fluids, restrict the last two hours before bedtime, and reduce caffeine.²
• Dietary fiber and adequate fluid intake support encopresis maintenance after disimpaction.⁶
• Treat comorbid ADHD with usual care; untreated ADHD predicts worse adherence to alarm therapy and toileting protocols.⁷
• School accommodations (unrestricted bathroom access, discreet change of clothing) reduce avoidance and humiliation.⁵

Most harms in elimination disorder treatment come from over-medicalization, coercive toileting, and unrecognized constipation, not the medications themselves. The evidence base is moderate overall, with stronger data for alarm therapy and PEG than for second-line pharmacotherapy.

Common adverse effects

• Desmopressin: headache, nausea, mild abdominal discomfort, and dose-related hyponatremia.^11-12
• Anticholinergics: dry mouth, constipation, blurred vision, flushing, cognitive or behavioral changes; constipation can paradoxically worsen enuresis.¹¹
• PEG 3350: bloating, flatulence, transient loose stools; rare reports of behavioral changes whose causal relationship to PEG remains debated.^6,13

Serious or rare adverse effects

• Desmopressin-induced hyponatremic seizures, particularly with intranasal formulations or excessive fluid intake.^11-12
• Imipramine cardiotoxicity in overdose; QT prolongation and arrhythmia risk at therapeutic doses in susceptible children.^2,11
• Severe stool impaction with electrolyte derangement during aggressive disimpaction.^6,13

Monitoring and discontinuation

• Desmopressin: monitor for symptoms of hyponatremia; check serum sodium with prolonged use or intercurrent illness; plan structured washouts every 3 months to assess for spontaneous remission.^11-12
• Anticholinergics: monitor stool patterns, dental caries (dry mouth), and behavior; reassess need every 6 months.¹¹
• PEG maintenance: continue for several months beyond the return of normal stool pattern to allow recovery of rectal tone; abrupt discontinuation is the most common cause of relapse.^6,13

Evidence-base limitations

• Most enuresis and encopresis trials are short (8–16 weeks), under-recruit girls and adolescents, and rarely report quality-of-life outcomes systematically.^2,4
• Comparative effectiveness data for newer agents (mirabegron, solifenacin) in children remain limited.^3,11
• Cultural variation in toilet training age complicates generalizability of effectiveness estimates.⁵

Subgroups change both the differential weighting and the acceptable treatment menu. The clinical question shifts from "what works?" to "what works safely for this child?"

Children with neurodevelopmental disorders

• ADHD substantially increases prevalence and worsens adherence to alarm therapy; treating ADHD often improves elimination outcomes.⁷
• Autism spectrum disorder commonly delays toilet training and produces sensory aversions that complicate behavioral programs; visual schedules and graded desensitization help.⁷
• Intellectual disability shifts the developmental-age threshold of DSM-5-TR criteria and influences treatment goals.⁹

Adolescents with persistent enuresis

• Persistence into adolescence carries higher psychosocial morbidity and warrants combined alarm and pharmacologic treatment, plus screening for obstructive sleep apnea.²
• Bullying and avoidance of social activities (overnight trips, sports) deserve direct clinical attention.^2,5

Perinatal and parental factors

• Maternal smoking during pregnancy and low birth weight are associated with increased risk of childhood enuresis.²
• Parental psychopathology and high family conflict predict worse outcomes and lower treatment adherence.^5,7

Children with comorbid medical illness

• Diabetes mellitus, sickle cell disease, and conditions requiring diuretics produce symptoms that overlap with enuresis; treatment focuses on the underlying condition.^1,3
• Spina bifida and neurogenic bladder require pediatric urology comanagement; standard enuresis pathways do not apply.³

Trauma exposure

• Sexual abuse should be considered in the differential of secondary encopresis or enuresis, especially when symptoms are accompanied by other behavioral changes, but the base rate of abuse among children with elimination disorders is low and screening must avoid leading questioning.^5,7

Cultural and structural factors

• Age and approach of toilet training vary widely across cultures; what is normative in one setting may be considered delayed in another.⁵
• Lack of access to private bathrooms at school, water insecurity, and crowded housing all impede behavioral programs.⁵

Spontaneous remission is the rule rather than the exception, but symptom resolution does not equal psychosocial recovery. The shame that accumulated during years of wetting or soiling can outlast the symptom itself.

Enuresis natural history

• Untreated nocturnal enuresis remits spontaneously at approximately 15% per year in school-aged children.^1-2
• By late adolescence, approximately 1–2% of individuals continue to have nocturnal enuresis.^1-2
• Daytime urinary incontinence tends to persist longer and is more likely to require active treatment.³

Encopresis natural history

• With adequate disimpaction and a 6–12 month maintenance laxative course, approximately 60–80% of children with retentive encopresis achieve sustained remission.^4,6
• Premature discontinuation of maintenance therapy is the leading cause of relapse.^6,13
• Non-retentive encopresis tends to be more chronic and more strongly tied to psychosocial factors.^5,7

Predictors of poor outcome

• Severity (frequency of wetting or soiling), comorbid ADHD or anxiety, high family conflict, and coercive parenting practices.^5,7
• Persistent daytime symptoms in addition to nighttime wetting.³
• Delayed presentation to care, often because of shame.⁵

Functional outcomes

• Self-esteem, peer relationships, and academic functioning improve measurably with successful treatment, with some studies suggesting that successful enuresis treatment improves quality-of-life scores more than equivalent treatment in chronic medical conditions.^2,14

Elimination disorders rarely produce a true psychiatric emergency, but the family system around them sometimes does.

Acute medical concerns

• New-onset polyuria with weight loss or polydipsia: rule out diabetes urgently with point-of-care glucose.¹
• Acute urinary retention or new neurologic signs: emergent evaluation for cord compression or neurogenic bladder.³
• Severe stool impaction with vomiting, abdominal distension, or electrolyte derangement: prompt medical management, sometimes inpatient.⁶

Hospitalization considerations

• Outpatient management is appropriate for nearly all elimination disorder cases.^4,6
• Hospitalization may be warranted for refractory disimpaction, severe psychosocial distress with safety concerns, or to remove the child from a coercive or abusive environment.^5,7

Most controversies in elimination disorders are about treatment sequencing and the relative weight given to behavioral, pharmacologic, and family-system interventions rather than core diagnostic categories.

Alarm vs. desmopressin as first-line:

• European and North American guidelines generally recommend alarm therapy as first-line for monosymptomatic nocturnal enuresis when families can adhere, but real-world adherence is low and desmopressin is often used first for pragmatic reasons.^2,12,14
• Combination therapy (alarm plus desmopressin) may improve short-term response in selected children but adds cost and complexity.^2,12

Role of psychotherapy in retentive encopresis

• Some specialists argue for early integrated behavioral-family therapy in all retentive cases; others reserve it for refractory presentations or clear psychosocial drivers.^4-5
• Trials directly comparing laxative-only protocols to laxative-plus-behavioral-therapy show added benefit for combined treatment, but effect sizes are modest.^4-5

Imipramine in modern practice

• Retained in some guidelines for refractory cases despite the cardiotoxicity profile; many pediatric centers no longer use it given safer alternatives.^2,11

Emerging agents

• Mirabegron (beta-3 agonist) and onabotulinumtoxinA injections have growing evidence in pediatric overactive bladder but are not yet first-line; data on long-term safety in children are limited.^3,11

Toilet training timing

• Earlier (before 18 months) vs. later (after 36 months) toilet training has been variably associated with later elimination disorder risk; current evidence does not support a single optimal age.⁵

• DSM-5-TR requires a chronologic or developmental age of at least 5 years for enuresis and at least 4 years for encopresis.⁹
• Enuresis requires wetting at least twice per week for three consecutive months, or clinically significant distress/impairment.⁹
• Encopresis requires at least one event per month for three consecutive months.⁹
• Retentive encopresis with overflow incontinence accounts for the substantial majority of encopresis cases; treat constipation first with PEG 3350.^4,6
• Enuresis alarm therapy is first-line for monosymptomatic nocturnal enuresis when family adherence is realistic; relapse is lower than with desmopressin.^2,14
• Intranasal desmopressin is not recommended for childhood enuresis due to risk of hyponatremic seizures; oral or sublingual is preferred.^11-12
• Primary nocturnal enuresis: never achieved sustained dryness for ≥6 months; secondary: relapse after ≥6 months dry interval.⁹
• Hirschsprung disease classically presents with delayed meconium passage (>48 hours) and empty rectum on exam, distinguishing it from functional constipation.^4,6
• A child with two parents who had enuresis has roughly a 70–75% risk of enuresis themselves.^2,8
• Constipation is bidirectionally linked to enuresis; treating constipation often improves daytime and nighttime wetting.^3,6
• Untreated nocturnal enuresis remits spontaneously at approximately 15% per year.^1-2
• Imipramine is rarely used for enuresis in modern practice due to cardiotoxicity in overdose.^2,11
• Secondary encopresis or enuresis after a sustained continent period warrants careful screening for medical mimics and psychosocial stressors including abuse.^5,7
• Punishment for wetting or soiling worsens outcomes and increases abuse risk; counsel families directly against it.^5,7

No external funding. No conflicts of interest declared. Peer-review status: pending.